Skip to main content

Regeneron hopes to have COVID-19 treatment by summer for testing

By Albany Times-Union  
   March 05, 2020

Regeneron Pharmaceuticals' CEO said Tuesday the company hopes to have its COVID-19 treatment ready for human testing by August. Leonard Schleifer, in an interview Tuesday on CNBC, said the company could have 200,000 doses ready by August, and that it would pursue both clinical trials and drug manufacturing simultaneously.

Full story

Get the latest on healthcare leadership in your inbox.